M. Boroujerdi

发表

Pharmacokinetics : Principles and Applications

M. Boroujerdi, 2001 .

Uptake capacity and adsorption isotherms of doxorubicin on polymeric nanoparticles: effect of methods of preparation

M. Boroujerdi, N. Bapat, 1992 .

Preclinical PK/TK and Clinical Trials

M. Boroujerdi, 2015 .

Metabolism of creatinine in vivo.

M. Boroujerdi, A. Mattocks, 1983, Clinical chemistry.

Metabolism and DNA binding of benzo(a)pyrene in vivo in the rat.

M. Boroujerdi, A. Wilson, M. Anderson, 1981, Cancer research.

Concentration dependency of modulatory effect of amlodipine on P‐glycoprotein efflux activity of doxorubicin — a comparison with tamoxifen

M. Boroujerdi, Ramin Darvari, 2004, The Journal of pharmacy and pharmacology.

Inhibition in vivo of the formation of adducts between metabolites of benzo(a)pyrene and DNA by butylated hydroxyanisole.

M. Boroujerdi, A. Wilson, M. Anderson, 1981, Cancer research.

Pharmacokinetics and Toxicokinetics

M. Boroujerdi, 2015 .

Effect of Colloidal Carriers on the Disposition and Tissue Uptake of Doxorubicin: II. Conjugation with Isobutyl-Cyanoacrylate Nanoparticles

M. Boroujerdi, N. Bapat, 1993 .

Investigation of the enterohepatic recirculation of Adriamycin and its metabolites by a linked-rat model

K. Behnia, M. Boroujerdi, 1998, Cancer Chemotherapy and Pharmacology.

Pharmacokinetic‐toxicodynamic Relationships of Adriamycin in Rat: Prediction of Butylated Hydroxyanisole‐mediated Reduction in Anthracycline Cardiotoxicity

M. Boroujerdi, J. Vora, Mehdi Boroujerdi, 1996, The Journal of pharmacy and pharmacology.

Pharmacokinetics and Tissue Uptake of Doxorubicin Associated With Erythroctte-nembrane:erithroctte-Ghosts vs Erythrocyte-Vesicles

M. Boroujerdi, A. Al-Achi, 1990 .

Investigation of the relative affinity of doxorubicin for neutral and negatively charged particulate carriers

M. Boroujerdi, N. Bapat, J. Vora, 1993 .

Protective Effect of Butylated Hydroxyanisole on Adriamycin‐induced Cardiotoxicity

M. Boroujerdi, J. Narula, B. Khaw, 1996, The Journal of pharmacy and pharmacology.

Contradistinction between doxorubicin and epirubicin: in‐vivo metabolism, pharmacokinetics and toxicodynamics after single‐ and multiple‐dosing in rats

M. Boroujerdi, S. Ramanathan-Girish, Sandhya Ramanathan‐Girish, 2001, The Journal of pharmacy and pharmacology.

Contradistinction between doxorubicin and epirubicin: in‐vitro interaction with blood components

M. Boroujerdi, S. Ramanathan-Girish, Sandhya Ramanathan‐Girish, 2001, The Journal of pharmacy and pharmacology.

Inhibition of Aldo‐keto Reductases by Phenobarbital Alters Metabolism, Pharmacokinetics and Toxicity of Doxorubicin in Rats

K. Behnia, M. Boroujerdi, Kamelia Behnia, 1999, The Journal of pharmacy and pharmacology.

Controlled Release Antibiotics for Treatment of Periodontal Disease

D. Wise, J. Gresser, M. Boroujerdi, 1998 .

Photophysical characterization of insulin denaturation and aggregation at hydrophobic interfaces

M. Boroujerdi, M. Amiji, Ekata Shah, 1995 .

Investigation of the influence of modulation of P-glycoprotein by a multiple dosing regimen of tamoxifen on the pharmacokinetics and toxicodynamics of doxorubicin

M. Boroujerdi, Ramin Darvari, 2005, Cancer Chemotherapy and Pharmacology.

Adsorption Isotherm for Doxorubicin on Erythrocyte-Membrane

M. Boroujerdi, A. Al-Achi, 1990 .

Interaction of dexrazoxane with red blood cells and hemoglobin alters pharmacokinetics of doxorubicin

M. Boroujerdi, S. Vaidyanathan, 2000, Cancer Chemotherapy and Pharmacology.

Stochastic Principles and Mathematical Analysis Useful in Dissolution Testing of a Solid Dosage Form

M. Boroujerdi, 1983 .

Calcitriol Reverses Induced Expression of Efflux Proteins and Potentiates Cytotoxic Activity of Gemcitabine in Capan-2 Pancreatic Cancer Cells.

M. Boroujerdi, Shabnam N. Sani, Hamed Gilzad-Kohan, 2017, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

Bioavailability, Bioequivalence, and Biosimilar Evaluations

M. Boroujerdi, 2015 .

PK/TK Analysis of Xenobiotics Absorbed via an Extravascular Route of Administration (Oral Administration)

M. Boroujerdi, 2015 .

Microvesicle removal of anticancer drugs contributes to drug resistance in human pancreatic cancer cells

Shaker A. Mousa, Kurunthachalam Kannan, S. Mousa, 2016, Oncotarget.

Time and concentration dependency of P-gp, MRP1 and MRP5 induction in response to gemcitabine uptake in Capan-2 pancreatic cancer cells

M. Boroujerdi, Hamed Gilzad Kohan, 2015, Xenobiotica; the fate of foreign compounds in biological systems.

The comparability of pharmacokinetics of creatinine in rabbit and man: a mathematical approach.

M. Boroujerdi, 1982, Journal of theoretical biology.

Effect of tamoxifen pretreatment on the pharmacokinetics, metabolism and cardiotoxicity of doxorubicin in female rats

M. Boroujerdi, S. Vaidyanathan, 2000, Cancer Chemotherapy and Pharmacology.

Enhanced Aqueous Solubility of Phenolic Antioxidants Using Modified β-Cyclodextrins

M. Boroujerdi, J. Vora, 1995 .

A nonlinear tissue-binding model for creatine: estimation of creatine turnover time and creatinine production rate.

M. Boroujerdi, 1986, Research communications in chemical pathology and pharmacology.

Biotransformation of Xenobiotics

M. Boroujerdi, 2015 .

Biotransformation of Xenobiotics

M. Boroujerdi, J. Timbrell, T. Marrs, 2015 .

Creatinine kinetics in the rabbit

M. Boroujerdi, A. Mattocks, 1979, Journal of Pharmacokinetics and Biopharmaceutics.